Elevance brushes off fears of spiking Medicare Advantage costs

Investors balked last week after UnitedHealth reported first-quarter MA utilization grew at twice its expected rate. Yet Elevance said spending was in line with expectations, a development one analyst called surprising.

Scroll to Top